Dr. Jérémie Calais on a Novel Radiotracer That Detects, Differentiates Renal Cell Carcinomas

By Jérémie Calais, MD, MSc - Last Updated: July 28, 2023

Jérémie Calais, MD, MSc, of the University of California, Los Angeles, highlights the current imaging and biopsy methods used for detecting and differentiating renal tumors, describes a novel radiotracer explored in the ZIRCON study, and explains how the recent data on this radiotracer further support its use.

Dr. Calais presented these updated data at the SNMMI 2023 Annual Meeting.

View more SNMMI 2023 Annual Meeting coverage.